Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours

Clinical Endocrinology

Volumn 75, Issue 5, 2011, Pages 673-677

  Stobo, David B ^a   Lindsay, Robert S ^b   Connell, John M ^c   Dunn, Laurence ^a   Forbes, Kirsten P ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ACTH SECRETING ADENOMA; ADULT; ARTICLE; CLINICAL ARTICLE; CUSHING SYNDROME; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GROWTH HORMONE SECRETING ADENOMA; HISTOLOGY; HUMAN; HYPOPHYSIS TUMOR; IMAGE QUALITY; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGIST; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO;

ACROMEGALY; ADRENOCORTICOTROPIC HORMONE; ADULT; FEMALE; GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS;

EID: 80054755358     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04098.x     Document Type: Article

References (51)

1. Parry, D.M., Li, F.P., Strong, L.C., et al. (1982) Carotid body tumors in humans: genetics and epidemiology. Journal of the National Cancer Institute, 68, 573-578. (Pubitemid 12078840)
2. Burnichon, N., Rohmer, V., Amar, L., et al. (2009) The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. Journal of Clinical Endocrinology and Metabolism, 94, 2817-2827.
3. Mannelli, M., Castellano, M., Schiavi, F., et al. (2009) Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. Journal of Clinical Endocrinology and Metabolism, 94, 1541-1547.
4. Neumann, H.P., Erlic, Z., Boedeker, C.C., et al. (2009) Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Research, 69, 3650-3656.
5. Badenhop, R.F., Jansen, J.C., Fagan, P.A., et al. (2004) The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features. Journal of Medical Genetics, 41, e99.
6. Erlic, Z., Rybicki, L., Peczkowska, M., et al. (2009) Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clinical Cancer Research, 15, 6378-6385.
7. van der Mey, A.G.L., Maaswinkel-Mooy, P.D., Cornelisse, C.J., et al. (1989) Genomic imprinting in hereditary glomus tumors-evidences for new genetic theory. Lancet, 2, 1291-1294. (Pubitemid 20005669)
8. Baysal, B.E., Ferrell, R.E., Willett-Brozick, J.E., et al. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science, 287, 848-851. (Pubitemid 30084326)
9. Astuti, D., Latif, F., Dallol, A., et al. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics, 69, 49-54. (Pubitemid 32614017)
10. Niemann, S., &, Muller, U., (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nature Genetics, 26, 268-270.
11. Mariman, E.C.M., Vanbeersum, S.E.C., Cremers, C.W.R.J., et al. (1995) Fine mapping of a putatively imprinted gene for familial nonchromaffin paragangliomas to chromosome 11q13.1-evidence for genetic-heterogeneity. Human Genetics, 95, 56-62.
12. Hao, H.X., Khalimonchuk, O., Schraders, M., et al. (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science, 325, 1139-1142.
13. Burnichon, N., Briere, J.J., Libe, R., et al. (2010) SDHA is a tumor suppressor gene causing paraganglioma. Human Molecular Genetics, 19, 3011-3020.
14. Boedeker, C.C., Erlic, Z., Richard, S., et al. (2009) Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. Journal of Clinical Endocrinology and Metabolism, 94, 1938-1944.
15. Peczkowska, M., Cascon, A., Prejbisz, A., et al. (2008) Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Nature Clinical Practice Endocrinology & Metabolism, 4, 111-115. (Pubitemid 351156901)
16. van Houtum, W.H., Corssmit, E.P., Douwes Dekker, P.B., et al. (2005) Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas. European Journal of Endocrinology, 152, 87-94. (Pubitemid 40185456)
17. Kunst, H.P., Rutten, M.H., De Monnink, J.P., et al. (2011) SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma. Clinical Cancer Research, 17, 247-254.
18. Benn, D.E., Gimenez-Roqueplo, A.P., Reilly, J.R., et al. (2006) Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. Journal of Clinical Endocrinology and Metabolism, 91, 827-836. (Pubitemid 43357746)
19. Neumann, H.P., Pawlu, C., Peczkowska, M., et al. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA, 292, 943-951. (Pubitemid 39097204)
20. Gimenez-Roqueplo, A.P., Favier, J., Rustin, P., et al. (2003) Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Research, 63, 5615-5621. (Pubitemid 37139886)
21. Brouwers, F.M., Eisenhofer, G., Tao, J.J., et al. (2006) High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. Journal of Clinical Endocrinology and Metabolism, 91, 4505-4509. (Pubitemid 44833431)
22. Havekes, B., Corssmit, E.P., Jansen, J.C., et al. (2007) Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. Journal of Clinical Endocrinology and Metabolism, 92, 1245-1248. (Pubitemid 46556393)
23. Timmers, H.J., Pacak, K., Bertherat, J., et al. (2008) Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clinical Endocrinology, 68, 561-566. (Pubitemid 351388709)
24. Hensen, E.F., van Duinen N., Jansen, J.C., et al. (2011) High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. Clinical Genetics, doi:. [Epub ahead of print].
25. Taschner, P.E.M., Jansen, J.C., Baysal, B.E., et al. (2001) Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes & Cancer, 31, 274-281. (Pubitemid 32521758)
26. Astrom, K., Cohen, J.E., Willett-Brozick, J.E., et al. (2003) Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Human Genetics, 113, 228-237. (Pubitemid 36992281)
27. Hermsen, M.A., Sevilla, M.A., Llorente, J.L., et al. (2010) Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management. Cell Oncology, 32, 275-283.
28. Ricketts, C.J., Forman, J.R., Rattenberry, E., et al. (2010) Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Human Mutation, 31, 41-51.
29. Cascon, A., Pita, G., Burnichon, N., et al. (2009) Genetics of pheochromocytoma and paraganglioma in Spanish patients. Journal of Clinical Endocrinology and Metabolism, 94, 1701-1705.
30. Zeegers, M.P., van Poppel, F., Vlietinck, R., et al. (2004) Founder mutations among the Dutch. European Journal of Human Genetics, 12, 591-600. (Pubitemid 39077169)
31. van Schothorst, E.M., Jansen, J.C., Grooters, E., et al. (1998) Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands. American Journal of Human Genetics, 63, 468-473. (Pubitemid 30418628)
32. Bayley, J.P., Kunst, H.P., Cascon, A., et al. (2010) SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. The Lancet Oncology, 11, 366-372.
33. van Baars, F., van den Broek, P., Cremers, C., et al. (1981) Familial non-chromaffinic paragangliomas (glomus tumors)-clinical aspects. The Laryngoscope, 91, 988-996. (Pubitemid 11111072)
34. Hensen, E.F., Jordanova, E.S., van Minderhout, I.J.H.M., et al. (2004) Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene, 23, 4076-4083. (Pubitemid 38747938)
35. Hensen, E.F., Goeman, J.J., Oosting, J., et al. (2009) Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis. BMC Medical Genomics, 2, 25.
36. Hes, F.J., Weiss, M.M., Woortman, S.A., et al. (2010) Low penetrance of a SDHB mutation in a large Dutch paraganglioma family. BMC Medical Genetics, 11, 92.
37. Bayley, J.P., van Minderhout, I.J.H.M., Weiss, M.M., et al. (2006) Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Medical Genetics, 7, 1.
38. Lüdecke, D.K., Flitsch, J., Knappe, U.J., et al. (2001) Cushing's disease: a surgical view. Journal of Neuro-Oncology 54, 151-166. (Pubitemid 33089248)
39. Lissett, C.A., Peacey, S.R., Laing, I., et al. (1998) The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clinical Endocrinology 49, 653-657. (Pubitemid 28529765)
40. Alvarez-Linera, J., (2008) 3T MRI: advances in brain imaging. European Journal of Radiology 67, 415-426.
41. Trattnig, S., Ba-Ssalamah, A., Noebauer-Huhmann, I.-M., et al. (2003) MR contrast agent at high-field MRI (3 Tesla). Topics in Magnetic Resonance Imaging 14, 365-375. (Pubitemid 37521728)
42. Armitage, P., &, Berry, G., (1994) Statistical Methods in Medical Research, 2nd edn. Blackwell Science, Oxford, UK, 449-450.
43. Pijl, M.E.J., Doornbos, J., van Houwelingen, H.C., et al. (2004) Quantitative analysis of focal masses at MR imaging: a plea for standardisation. Radiology 231, 737-744. (Pubitemid 38668091)
44. Wolfsberger, S., Ba-Ssalamah, A., Pinker, K., et al. (2004) Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions. Journal of Neurosurgery 100, 278-286. (Pubitemid 38140232)
45. Cano, A., Martinez, M., Benito, P., et al. (1998) Analysis of indirect signs of microprolactinoma at MR imaging. European Journal of Radiology 31, 157-164.
46. Jehle, S., Walsh, J.E., Freda, P.U., et al. (2008) Selective use of bilateral inferior petrosal sinus sampling in patients with adrenocorticotropin- dependent Cushing's syndrome prior to transsphenoidal surgery. The Journal of Clinical Endocrinology and Metabolism 93, 4624-4632.
47. Sonksen, P., &, Sonksen, C., (2008) Pituitary incidentaloma. Clinical Endocrinology 69, 180. (Pubitemid 352009036)
48. Pinker, K., Ba-Ssalamah, A., Wolfsberger, S., et al. (2005) The value of high-field MRI (3T) in the assessment of sellar lesions. European Journal of Radiology 54, 327-334. (Pubitemid 40719722)
49. Kim, L.J., Lekovic, G.P., White, W.L., et al. (2007) Preliminary experience with 3-Tesla MRI and Cushing's disease. Skull Base 17, 273-278.
50. Salenave, S., Gatta, B., Pecheur, S., et al. (2004) Pituitary magnetic resonance imaging findings do not influence surgical ourcome in adrenocorticotropin-secreting microadenomas. The Journal of Clinical Endocrinology and Metabolism 89, 3371-3376. (Pubitemid 38951906)
51. Ikeda, H., Abe, T., &, Watanabe, K., (2010) Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma. Journal of Neurosurgery 112, 750-755.